Open this publication in new window or tab >> Show others...
2024 (English) In: Journal of Alzheimer's Disease, ISSN 1387-2877, E-ISSN 1875-8908, Vol. 99, no 2, p. 799-810Article in journal (Other academic) Published
Abstract [en] This contribution corrects cost data from our previously published version in which the 6-month cost data was not censored at baseline and 6-month survey dates. Consequently, the average costs for persons with mild cognitive impairment (PwMCI) and their informal caregivers include costs that occurred outside the initial 6-month period for both intervention and control groups. In this erratum, we have repeated the analysis after appropriately censoring the costs. The results led to numerical differences. However, as both the intervention and control groups have been treated exactly the same, the differences between groups remain insignificant and the general interpretation of the results stand as presented in the original publication. The interpretation of the results in terms of cost-effectiveness has changed for informal caregivers, shifting from "dominant" to "not cost-effective", and for dyads, shifting from "less costly and less effective" to "more costly and less effective". Consequently, ICER and CEAC curves have also changed (see Corrected Fig. 1). However, these changes did not affect the conclusion of the article.
Keywords aged, Alzheimer disease, caregiver, clinical article, controlled study, cost effectiveness analysis, dementia, disease management, drug therapy, economic evaluation, informal caregiver, memory, mild cognitive impairment, mobile application, smartphone, telehealth, therapy, erratum
National Category
Health Care Service and Management, Health Policy and Services and Health Economy
Research subject
Applied Health Technology
Identifiers urn:nbn:se:bth-26986 (URN) 10.3233/jad-249009 (DOI) 38701171 (PubMedID) 2-s2.0-85193646507 (Scopus ID)
2024-10-082024-10-082024-10-15 Bibliographically approved